| Preoperative | 6 months after the operation | End of follow-up |
---|---|---|---|
Stage | |||
 Phase I | 5.0 ± 0.8 | 2.0 ± 0.8** | 0.4 ± 0.5** |
 Phase II | 5.1 ± 0.7 | 2.8 ± 0.8** | 5.1 ± 2.9 |
Pathogeny | |||
 AFHN | 4.8 ± 0.8 | 1.8 ± 0.8** | 0.2 ± 0.4** |
 SIFHN | 5.25 ± 0.9 | 3.25 ± 0.9** | 7.25 ± 0.9** |
 IFHN | 5.1 ± 0.7 | 2.4 ± 0.5** | 2.7 ± 2.6* |
Total | 5.1 ± 0.8 | 2.4 ± 0.9** | 3.1 ± 3.2* |